Doctors Note Logo

Published on: 5/22/2026

Why Nasal Polyps May Grow Back After Stopping Dupixent: The True Science

Stopping Dupixent lifts the blockade on IL-4 and IL-13 signals, allowing eosinophils and mucosal inflammation to return and often leading to polyp regrowth within weeks to months. Underlying triggers like allergies, structural sinus issues, and eosinophil memory that are not permanently altered by the drug fuel this rebound.

There are several factors that affect how quickly and how much polyps return and important strategies to slow recurrence, so see below for more details that could impact your next steps.

answer background

Explanation

Why Nasal Polyps May Grow Back After Stopping Dupixent: The True Science

Stopping Dupixent do nasal polyps grow back fast? Many people wonder what happens when they pause or stop dupilumab (Dupixent) treatment for chronic sinusitis with nasal polyps. Dupixent can dramatically shrink polyps and relieve symptoms, but nasal polyps often return once the drug is discontinued. Here's the real science behind why and how quickly that can happen, without sugar-coating the facts or causing undue alarm.

Understanding Nasal Polyps and Their Causes

Nasal polyps are benign, grape-like growths inside the nasal passages and sinuses. They develop due to chronic inflammation and are most common in people with:

  • Asthma or aspirin-exacerbated respiratory disease (AERD)
  • Allergic rhinitis or environmental allergies
  • Chronic sinus infections
  • Cystic fibrosis

Key drivers of polyp growth include:

  • Type 2 inflammation: Overactive immune signals (especially interleukins IL-4, IL-5, IL-13)
  • Eosinophils: White blood cells that release inflammatory mediators
  • Mucosal remodeling: Thickening of sinus lining, increased fluid secretion

Left unchecked, this cycle of inflammation leads to polyp formation, nasal congestion, loss of smell, headaches, and recurrent infections.

How Dupilumab (Dupixent) Works

Dupixent is a biologic therapy that targets the root of type 2 inflammation: it blocks the receptors for two key cytokines, IL-4 and IL-13. By interrupting these signals, Dupixent:

  • Reduces eosinophil activation and recruitment
  • Decreases production of mucus and inflammatory proteins
  • Lessens tissue edema (swelling) in sinus linings
  • Shrinks nasal polyps over weeks to months

Clinical trials (SINUS-24 and SINUS-52) showed that most patients experienced significant polyp size reduction and better symptom scores within 16 weeks of starting Dupixent, with continued benefit through one year.

Why Polyps Often Return After Stopping Dupixent

When you stop Dupixent, the underlying drivers of inflammation can re-emerge:

  1. Cytokine Rebound

    • IL-4 and IL-13 activity may resume within weeks of stopping the drug.
    • This reactivation fuels eosinophil influx and mucus secretion.
  2. Persistent Inflammatory Triggers

    • Allergens, irritants, infections, and aspirin in sensitive individuals continue to provoke type 2 inflammation.
    • Structural issues (e.g., narrow sinus openings) remain uncorrected without surgery.
  3. Mucosal Remodeling

    • Long-standing inflammation alters sinus tissue architecture.
    • Even after polyps shrink, the lining can remain prone to edema and regrowth.
  4. Eosinophil Memory

    • Some studies suggest eosinophil precursors can persist in bone marrow and rapidly repopulate tissues.

Because these processes aren't permanently reversed by Dupixent, polyps can regrow once the blockade on IL-4/IL-13 is lifted.

How Fast Do Polyps Grow Back?

The speed of regrowth varies by individual but in many trials and real-world reports:

  • Weeks to Months: Some patients notice mild symptom return as early as 4–8 weeks after the last dose.
  • 3–6 Months: Polyp size and nasal obstruction often approach pre-treatment levels by 3–6 months off therapy.
  • Longer-Term: Without re-treatment or other interventions, polyps can fully recur within a year.

Factors that influence regrowth speed include:

  • Baseline polyp size and severity
  • Presence of asthma or AERD
  • Ongoing allergen exposure
  • Whether you had sinus surgery in the past

In essence, stopping Dupixent often allows the same inflammatory environment to re-establish itself, which can lead to relatively fast polyp return.

Clinical Evidence at a Glance

  • SINUS-52 Extension Study: Patients who missed Dupixent doses for 12 weeks saw increases in polyp size and symptom scores, though not always back to baseline immediately.
  • Real-World Observations: Clinicians report that many patients require re-initiation of Dupixent or alternative treatments within 4–6 months to maintain relief.

This doesn't mean everyone will have the exact same timeline, but it underscores that nasal polyps are a chronic condition driven by ongoing inflammation.

Managing Recurrence After Stopping Dupixent

If you or your doctor decide to pause Dupixent, consider these strategies to slow polyp regrowth:

• Intranasal corticosteroids
• Short courses of oral steroids (for flare-ups)
• Saline rinses and nasal hygiene
• Allergen avoidance and allergy immunotherapy (when relevant)
• Aspirin desensitization (in AERD patients)
• Surgical options (endoscopic sinus surgery to widen sinus openings)
• Lifestyle adjustments (e.g., smoking cessation, air filtration)

Regular follow-up with an ENT specialist or allergist can help you monitor for early signs of regrowth and adjust your plan accordingly.

Balancing Benefits, Risks, and Costs

Dupixent is highly effective but also expensive, and some patients face insurance or access challenges. Discuss with your care team:

  • Is long-term maintenance on Dupixent right for you?
  • Could intermittent therapy plus other measures suffice?
  • What monitoring schedule makes sense to catch regrowth early?

Shared decision-making ensures you get relief while managing side effects, budget, and quality of life.

When to Seek Help

If you notice any of the following after stopping Dupixent, talk to your doctor promptly:

  • Worsening nasal blockage or drainage
  • Significant loss of smell or taste
  • Frequent sinus infections
  • Asthma worsening or new wheezing
  • Severe facial pain or pressure

To help identify your symptoms and understand when to seek care, try Ubie's free Medically approved AI Symptom Checker for personalized guidance based on your specific situation.

Always speak to your healthcare provider about anything that could be life-threatening or serious.

Key Takeaways

  • Dupixent blocks IL-4/IL-13 to shrink nasal polyps effectively.
  • Underlying type 2 inflammation and mucosal changes persist after stopping therapy.
  • Polyps often return within weeks to months; full regrowth can occur by one year.
  • Strategies like nasal steroids, surgery, and allergen control can help slow recurrence.
  • Work closely with your doctor to balance treatment benefits, risks, and costs.
  • If symptoms worsen, use Ubie's Medically approved LLM Symptom Checker Chat Bot to understand your condition better and consult your provider.

Nasal polyps are a chronic, inflammatory condition. Stopping Dupixent may lead to fairly rapid regrowth, but proactive measures and close medical supervision can help you maintain control over your symptoms. Always speak to a doctor about any serious or life-threatening concerns.

(References)

  • * Luong A, Peters AT, Laidlaw T, Han JK, Kern RC, Schlosser RJ, Sacks WJ, Lam K, Mullol J, Hellings PW, Sanyal S, Fan C, Pirozzi G, Yancopoulos GD, Staudinger H, Mannent LP, Weinreich DM, Gandhi NA, Khan A, Geng B. Sustained improvement and disease recurrence after dupilumab discontinuation in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2023 Dec;11(12):3736-3747.e3. doi: 10.1016/j.jaip.2023.08.016. Epub 2023 Aug 21. PMID: 37604313.

  • * Hopkins C, Soni M, Marfaing-Koka A, Staudinger H, Mannent LP, Geng B, Fan C, Yancopoulos GD, Weinreich DM, Gandhi NA, Khan A, Sacks WJ. Disease control and relapse after dupilumab treatment in chronic rhinosinusitis with nasal polyps: a real-world study. Laryngoscope. 2024 Jan;134(1):251-258. doi: 10.1002/lary.30906. Epub 2023 Jul 4. PMID: 37398939.

  • * Chen C, Zhang H, Zhang H, Yuan Z. Recurrence of chronic rhinosinusitis with nasal polyps after cessation of dupilumab: A systematic review and meta-analysis. Front Pharmacol. 2023 Sep 8;14:1248039. doi: 10.3389/fphar.2023.1248039. PMID: 37744315; PMCID: PMC10515152.

  • * Zhang M, Chang C, Chitsuthipakorn W, Chen YC, Chu CW, Chien TJ, Lin HC, Weng Z, Hung CH, Chien CY. Real-World Effectiveness of Dupilumab for Chronic Rhinosinusitis With Nasal Polyps: A Multi-Institutional Study on Discontinuation and Relapse. Am J Rhinol Allergy. 2024 Jan;38(1):110-117. doi: 10.1177/19458924231210870. Epub 2023 Nov 14. PMID: 37965385.

  • * Arakawa S, Masuda S, Hirai T, Yamamoto H, Haruna S, Asano K, Oishi H. Risk factors for relapse after discontinuation of dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol. 2024 Feb;281(2):653-659. doi: 10.1007/s00405-024-08428-w. Epub 2024 Feb 5. PMID: 38317075.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.